Home Page News Statistics API Review Formulation Monthly Im&Ex report All Information
     
Keyword:
 E-mail:xuezhe@healthoo.com
 Tel.:86-10-68032463
  Our services:
 China Im\Ex data service
 Service fees of Chinese Vision
 Our service items
Online information introduction
Monthly information
Conference on ...
Information Release...
Internationalization&nbs...
Welcome to Pro...
Healthoo.com Carbap...
APIs Innovation&nbs...
China Import Export Statistics Report In...
API Export Price by ...
Tylosin Bulk Drug Export&...
China Monthly Export Stat...
China Monthly Export Stat...
China Monthly Export Stat...
Your position:www.healthoo.com >> EN >> Pharmaceutical News
Guobang Pharma won good harvest in first half year2010-09-09
China will be 3rd biggest pharmaceutical market in next 3 years2010-09-09
Daxin Pharma will conduct workshop upgrade2010-09-09
Capacity of L-carnitine in China expands in recent years2010-09-08
Hisun immunowuppressant got EU marketing approval2010-09-07
More than 20 producers of finished drugs passed EU or FDA authentication in China2010-09-07
Eisai brings new antidiabetes drug to China2010-09-06
Zhejiang Garden raises money to stretch its Vitami D3 product line2010-09-02
922.4 thousand medical organizations in China up to July2010-09-02
United Laboratories raised price of 2 bulk drugs2010-09-01
Senary begins to produce intermediates of Pioglitazone and Glimepiride.2010-09-01
Wuyi MSG to expand capacities of Mycophenolic acid and Sisomicin2010-09-01
The largest production base of antitumor agents launch Shanxi2010-08-31
Sinopharm is building antibiotics base in Datong2010-08-31
Guangji Pharma will soon resume Riboflavin production2010-08-30
Tuoyang passed environmental acceptance check for Vitamin C2010-08-30
Boehringer Ingelheim opens new research center in Shanghai2010-08-30
Lukang Pharma expanded its L-tryptophane production2010-08-27
Nixia Qiyuan will proceed overhaul2010-08-26
VC manufacturers suspend price offering2010-08-26
CSPC got one more EU certificate2010-08-25
BioPharm Asia negotiating to acquire WFMH2010-08-24
Renhuang Pharma names new interim CFO2010-08-23
Ouyi Pharma to upgrade its Azithromycin workshop2010-08-20
Southwest Synthetic will stop VE production temporarily2010-08-19
Dongyao Pharma to build Erythromycin Thiocyanate project2010-08-18
China-Biotics will build new probiotics facilities2010-08-18
Phase IIb trial of Sifuvirtide gets positive result in China2010-08-17
Export value of Chinese plant extracts increases steadily2010-08-16
NHU stops producing Vitamin A for 9 weeks2010-08-13
TCM going global with new alliance2010-08-13
Fengyuan builds Natamycin project in Qiqihar2010-08-13
4532个 页次:109/14232个/页 首页 上一页 下一页 尾页 转到:
Our Advantages of Reports
①All reports written by ourselves
②All data having original sources
③Information is the latest
④Continuous historical data
⑤Objective analysis and remark
Purchase Flow of Reports
①Confirm purchase (If necessary sign the contract)
②Transfer payment to company's bank account
③After accepting payment we email the report to clients (PDF format)
④Send the invoice
Bank account
①Beneficiary's Name:Beijing orientbit technology ltd
②Beneficiary's Account No.:110060239018002127366
③Name of bank:Bank of Communications Beijing Branch,Fuwai Sub-Branch
④Address of bank:NO7,FUWAISTREET,XICHENG DISTRICT,BEIJING,CHINA SWIFT CODE:COMMCNSHBJG
Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
Tel:+86-10-68032463